PCN303 - Assessment of Burden and Economic Impact of the Vandetanib Restricted Distribution Program in Canada
| Autor: | Frise, S, Bergamasco, A, Kozmenko, M, Salvo, F, Moride, Y |
|---|---|
| Zdroj: | In Value in Health November 2015 18(7):A484-A484 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect